1.89850 EUR
0.1105
5.50%
Last update Dec 16, 8:00 AM CET
Market closed
Day range
1.89850
1.89850
Previous close
2.0090001
Open
1.89850
Access this stock data via API
Subscribe
ImmunityBio, Inc.
1.90
0.11
5.50%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 12.6M 622K 240K 934K
Cost of revenue 0
Gross profit 12.6M
Operating expense
Research & development 162.0M 232.4M 248.1M 196.0M
Selling general and admin 143.8M 129.6M 102.7M 135.3M
Other operating expenses
Operating income -293.2M -361.4M -350.6M -330.3M
Non operating interest income
Income 2.0M 863K 2.7M 836K
Expense 112.1M 129.2M 63.5M 14.8M
Other income expense 70.2M -94.2M -5.9M -5.5M
Pretax income -352.3M -583.9M -417.3M -349.8M
Tax provision 0 -40K 34K 9K
Net income -352.3M -583.9M -417.3M -349.8M
Basic EPS -0.6 -1.2 -1.0 -0.9
Diluted EPS -0.6 -1.2 -1.0 -0.9
Basic average shares 593.9M 533.4M 416.2M 405.1M
Diluted average shares 593.9M 533.4M 416.2M 405.1M
EBITDA -258.5M -388.0M -342.5M -315.8M
Net income from continuing op. -352.3M -583.9M -417.3M -349.8M
Minority interests 81K 656K 753K 3.1M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 6 hours 30 minutes

01:29
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).